Faculty

Julia Lea Ziegengeist, PharmD, BCOP (Moderator)

Clinical Pharmacist Specialist, 
Breast Medical Oncology, Pharmacy Services 
Levine Cancer, Barbara L. Levine Oncology Breast & Cutaneous Center
Charlotte, NC

Dr. Julia Ziegengeist practices as a Clinical Pharmacist Specialist for solid tumor oncology specializing in breast cancer at Atrium Health Levine Cancer in Charlotte, North Carolina. She completed her PGY-1 Pharmacy Residency and PGY-2 Oncology Pharmacy Residency at Virginia Commonwealth University in Richmond, Virginia in 2018 and 2019, respectively. Since completion of residency, her primary oncology practice site has been within the Levine Cancer Institute Breast Medical Oncology Clinic, where she works alongside providers and APPs to ensure quality cancer care by tailoring treatment options and subsequent toxicity management to individual patients. She is a board-certified oncology pharmacist and her professional interests include patient education, toxicity management, and expansion of clinical pharmacy services within oncology.

Anna Tsipenyuk, PharmD, (Speaker)

Anna Tsipenyuk is a licensed pharmacist practicing in Chicago, Illinois, and a 2025 graduate of University of Illinois of Chicago Retzky College of Pharmacy. Throughout her pharmacy training, Dr. Tsipenyuk has completed a diverse range of clinical experiences across specialty pharmacy, oncology, ambulatory care, critical care, transplant, community pharmacy, and health-system administration. Her advanced pharmacy practice experiences at UI Health included rotations in specialty oncology pharmacy, ambulatory care, transplant, critical care, and specialty pharmacy administration.

Dr. Tsipenyuk has maintained a strong interest in oncology and specialty pharmacy throughout her professional development. She has completed both ambulatory and inpatient oncology experiences at UI Health and was actively involved with the Network for Collaborative Oncology Development and Advancement (NCODA), serving as Director of Programming for her student chapter and as a member of the Topics Committee. Dr. Tsipenyuk's scholarly work includes oncology-focused journal clubs, case presentations, investigational drug services projects, and research involving breast cancer and specialty oncology pharmacy practice.

Dr. Tsipenyuk currently practices as a community pharmacist in Chicago, while continuing to purse her interests in oncology.

Program Planners

Julia Lea Ziegengeist, PharmD, BCOP

Clinical Pharmacist Specialist, 
Breast Medical Oncology, Pharmacy Services 
Levine Cancer, Barbara L. Levine Oncology Breast & Cutaneous Center
Charlotte, NC

Dr. Julia Ziegengeist practices as a Clinical Pharmacist Specialist for solid tumor oncology specializing in breast cancer at Atrium Health Levine Cancer in Charlotte, North Carolina. She completed her PGY-1 Pharmacy Residency and PGY-2 Oncology Pharmacy Residency at Virginia Commonwealth University in Richmond, Virginia in 2018 and 2019, respectively. Since completion of residency, her primary oncology practice site has been within the Levine Cancer Institute Breast Medical Oncology Clinic, where she works alongside providers and APPs to ensure quality cancer care by tailoring treatment options and subsequent toxicity management to individual patients. She is a board-certified oncology pharmacist and her professional interests include patient education, toxicity management, and expansion of clinical pharmacy services within oncology.

Marshall Winget, PharmD, BCOP

Inpatient Clinical Pharmacist
Malignant Hematology/Bone Marrow Transplant
Duke University Hospital, Durham
Durham, NC

Marshall Winget is a malignant hematology inpatient clinical pharmacist at Duke University Hospital. He earned his undergraduate degree from the University of Minnesota and his Doctor of Pharmacy from the University of North Carolina Eshelman School of Pharmacy. He then completed his PGY1 Pharmacy Practice Residency and PGY2 Oncology Pharmacy Residency at Vanderbilt University Medical Center in Nashville, Tennessee. His professional interests and research focus on lymphomas, cellular therapies, and cardio-oncology.

Shawn Griffin

Oncology Pharmacist/Assistant Clinical Professor
University of California, Irvine 
Irvine, California

Shawn Griffin is a Board Certified Oncology Pharmacist and Health Sciences Assistant Clinical Professor in the Department of Clinical Pharmacy Practice at the University of California, Irvine (UCI) School of Pharmacy & Pharmaceutical Sciences. He practices within the Hematopoietic Stem Cell Transplantation and Cellular Therapy Program at the Chao Family Comprehensive Cancer Center. Prior to joining UCI, Griffin worked as a Hematology/Stem Cell Transplant pharmacist at Indiana University Health for five years. He received PharmD from the UNC Eshelman School of Pharmacy and completed a PGY1 Pharmacy and PGY2 Oncology Pharmacy Residency at the University of Florida Health Shands Hospital.

Disclosures

Horizon CME requires all planners, faculty, and other contributors to disclose any financial relationships with an ACCME defined ineligible company within the past 24 months and Horizon CME has resolved any conflicts prior to this educational activity.
Planners

*Horizon CME has mitigated and resolved all relevant financial relationships

Those others involved in the planning of this activity disclosed no relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Other Contributors

Other Contributors

All other non-faculty contributors and others involved in the planning, development and editing/review of the content disclosed no relevant financial relationships with any entity producing, marketing, re-selling or distributing health care goods or services consumed by or used on patients.